ABIOMED
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
108.16 | 57.21 | 89.06% | 74.98 | +44.26% |
| P/S |
|
14.31 | 33.44 | -57.2% |
|
|
| P/BV |
|
9.82 | 4.65 | 111.32% |
|
|
| P/FCF |
|
68.83 | 42.56 | 61.72% |
|
|
| Ev/Ebitda |
|
54.5 | -17.68 | -408.31% |
|
|
| Ev/S |
|
14.18 | 22.52 | -37.04% |
|
|
| Ev/FCF |
|
58.61 | 47.58 | 23.18% |
|
|
| E/P |
|
0.0079 | 0.0188 | -57.98% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
26.02 | -13.3 | -295.66% | 31.59 | -17.61% |
| ROE |
|
9.64 | 9.69 | -0.5523% |
|
|
| ROA |
|
8.62 | 0.2896 | 2875.93% |
|
|
| ROIC |
|
7.12 | 7.63 | -6.74% |
|
|
| ROS |
|
13.23 | -25.08 | -152.76% |
|
|
| ROCE |
|
15.99 | 14.58 | 9.71% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0372 | -3.62 | -101.03% | 0.0583 | -36.17% |
| Nеt Debt/Ebitda |
|
-0.4946 | -4.05 | -87.79% |
|
|
| Debt/Ratio |
|
0.006 | 0.1841 | -96.75% |
|
|
| Debt/Equity |
|
0.0494 | 1.6 | -96.91% |
|
|
| Debt/Net Income |
|
0.0733 | 0.9168 | -92.01% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5448 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4954 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5448 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
73.78 | 31.71 | 132.67% | ||
| Growth impulse Ebitda in 5 years |
|
56.64 | -23.28 | -343.3% | ||
| Growth impulse Net Income in 5 years |
|
21.66 | -61.56 | -135.19% | ||
| Growth impulse FCF in 5 years |
|
82.61 | -26 | -417.73% | ||
| Growth impulse EPS in 5 years |
|
21.44 | -63.63 | -133.69% |
IP Score
4.76/10
